Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;23(4):324-340.
doi: 10.1111/bdi.13040. Epub 2021 Jan 7.

Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms

Affiliations

Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms

Norma Verdolini et al. Bipolar Disord. 2021 Jun.

Abstract

Objectives: This systematic review aimed at providing a critical, comprehensive synthesis of international guidelines' recommendations on the long-term treatment of bipolar disorder type I (BD-I).

Methods: MEDLINE/PubMed and EMBASE databases were searched from inception to January 15th, 2019 following PRISMA and PICAR rules. International guidelines providing recommendations for the long-term treatment of BD-I were included. A methodological quality assessment was conducted with the Appraisal of Guidelines for Research and Evaluation-AGREE II.

Results: The final selection yielded five international guidelines, with overall good quality. The evaluation of applicability was the weakest aspect across the guidelines. Differences in their updating strategies and the rating of the evidence, particularly for meta-analyses, randomized clinical trials (RCTs) and observational studies, could be responsible of some level of heterogeneity among recommendations. Nonetheless, the guidelines recommended lithium as the 'gold standard' in the long-term treatment of BD-I. Quetiapine was another possible first-line option as well as aripiprazole (for the prevention of mania). Long-term treatment should contemplate monotherapy, at least initially. Clinicians should check regularly for efficacy and side effects and if necessary, switch to first-line alternatives (i.e. Valproate), combine first-line compounds with different mechanisms of action or switch to second-line options or combinations.

Conclusions: The possibility to monitor improvements in long-term outcomes, namely relapse prevention and inter-episode subthreshold depressive symptoms, based on the application of their recommendations is an unmet need of clinical guidelines. In terms of evidence of clinical guidelines, there is a need for more efficacious treatment strategies for the prevention of bipolar depression.

Keywords: bipolar disorder type I; clinical guidelines; long-term treatment; maintenance; practice algorithms.

PubMed Disclaimer

References

REFERENCES

    1. Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Prim. 2018;4:18008. https://doi.org/10.1038/nrdp.2018.8.
    1. Carvalho A, Firth J, Vieta E. Bipolar disorder. N Engl J Med. 2020;383(1):58-66. https://doi.org/10.1056/NEJMRA1906193.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edn). Arlington, VA: American Psychiatric Association; 2013.
    1. Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561-1572. https://doi.org/10.1016/S0140-6736(15)00241-X.
    1. Samalin L, Murru A, Vieta E. Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother. 2016;16(6):659-670. https://doi.org/10.1080/14737175.2016.1176530.

Publication types

MeSH terms